Genomma Lab Internacional SAB De CV (LABB)

Currency in MXN
17.670
+0.040(+0.23%)
Closed·
Unusual trading volume
High dividend Yield
LABB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.37017.840
52 wk Range
15.89026.060
Key Statistics
Bid/Ask
17.70 / 17.73
Prev. Close
17.63
Open
17.58
Day's Range
17.37-17.84
52 wk Range
15.89-26.06
Volume
7.27M
Average Volume (3m)
3.48M
1-Year Change
-28.8074%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LABB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
26.200
Upside
+48.27%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Genomma Lab Internacional SAB De CV Company Profile

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Employees
1708
Market
Mexico

Compare LABB to Peers and Sector

Metrics to compare
LABB
Peers
Sector
Relationship
P/E Ratio
10.7x15.4x−0.5x
PEG Ratio
−0.470.090.00
Price/Book
1.5x1.9x2.6x
Price / LTM Sales
1.0x2.4x3.2x
Upside (Analyst Target)
58.8%11.9%51.4%
Fair Value Upside
Unlock6.9%8.5%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 26.200
(+48.27% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Hold20.00+13.19%24.00MaintainFeb 18, 2026

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.65%
Dividend Yield
4.53%
Industry Median 2.29%
Annualized payout
0.80
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 26, 2026
EPS / Forecast
0.32 / 0.52
Revenue / Forecast
4.02B / 4.38B
EPS Revisions
Last 90 days

LABB Income Statement

People Also Watch

201.050
GMEXICOB
-5.59%
56.310
WALMEX
-0.79%
21.610
AMXB
-2.00%
192.29
FEMSAUBD
-2.16%
192.880
GFNORTEO
-2.29%

FAQ

What Is the Genomma Lab Int (LABB) Stock Price Today?

The Genomma Lab Int stock price today is 17.670 MXN.

What Stock Exchange Does Genomma Lab Int Trade On?

Genomma Lab Int is listed and trades on the Mexico Stock Exchange.

What Is the Stock Symbol for Genomma Lab Int?

The stock symbol for Genomma Lab Int is "LABB."

Does Genomma Lab Int Pay Dividends? What’s The Current Dividend Yield?

The Genomma Lab Int dividend yield is 4.53%.

What Is the Genomma Lab Int Market Cap?

As of today, Genomma Lab Int market cap is 17.260B MXN.

What Is Genomma Lab Int's Earnings Per Share (TTM)?

The Genomma Lab Int EPS (TTM) is 1.646.

When Is the Next Genomma Lab Int Earnings Date?

Genomma Lab Int will release its next earnings report on Apr 29, 2026.

From a Technical Analysis Perspective, Is LABB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Genomma Lab Int Stock Split?

Genomma Lab Int has split 1 times.

How Many Employees Does Genomma Lab Int Have?

Genomma Lab Int has 1708 employees.

What is the current trading status of Genomma Lab Int (LABB)?

As of Mar 06, 2026, Genomma Lab Int (LABB) is trading at a price of 17.670 MXN, with a previous close of 17.630 MXN. The stock has fluctuated within a day range of 17.370 MXN to 17.840 MXN, while its 52-week range spans from 15.890 MXN to 26.060 MXN.

What Is Genomma Lab Int (LABB) Price Target According to Analysts?

The average 12-month price target for Genomma Lab Int is 26.200 MXN, with a high estimate of 30 MXN and a low estimate of 20 MXN. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +48.27% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.